CL leverages pricing power, premium innovation and productivity initiatives to drive growth, expand margins and strengthen brand momentum.
June is shaping up as a stock-picker's month. Spring volatility has settled, and contrarian investors are scanning the wreckage for quality names trading well off their highs with identifiable recovery catalysts.
Shares of Robinhood (NASDAQ:HOOD | HOOD Price Prediction) are surging in midday trading on Wednesday, June 17, with the stock up 12% to roughly $109.
AeroVironment, Inc. (NASDAQ:AVAV) will report fiscal fourth-quarter earnings after the market closes on Monday, June 29.
Botanix's shutdown has raised an uncomfortable question for Bitcoin builders: Does the market actually want programmable BTC, or just a better way to borrow, lend and earn yield on it?
Fed removes easing bias and silver falls as traders price out 2026 rate cuts, putting the 200-day moving average at $68.72 in focus.
Among the various corners of the stock market, few have attracted as much attention as rare-earth element companies. This comes as the global economy looks to loosen China's grip on this market by investing in non-Chinese supply chains.
Blue Owl Capital remains a hold as macro uncertainty and tight dividend coverage offset improved liquidity and leverage. OBDC trades at a 22.5% discount to NAV and offers an 11% forward dividend yield after a recent 16% dividend cut. Leverage improved to 1.13x, non-accruals declined, and Moody's upgraded OBDC to Baa2, enhancing balance sheet strength.
Vanda Research's Viraj Patel walked CNBC viewers through one of the strangest sessions of the year on June 16, with a direct message: Retail investors sold the rest of the market to fund a single bet on SpaceX (NASDAQ:SPCX).
Pfizer Inc. remains a Buy with 55%+ upside potential over two years, driven by a robust pipeline and undervalued forward earnings. PFE's Q1 2026 results beat estimates, with non-COVID sales up 7% YoY and strong contributions from Seagen and new product launches. Key catalysts include the potential blockbuster GLP-1 candidate berobenatide, aggressive oncology growth, and patent settlements extending revenue streams.
QCP warns Strategy's note buyback and dividend pressure keep Bitcoin capped below $66,000.
KEFI Gold and Copper Plc (KFFLF) Discusses Share Issuance Impact and Tulu Kapi Project Development Progress Transcript
Elon Musk's personal fortune has surpassed the market value of Bitcoin, a milestone that shows how quickly SpaceX's public-market debut has reshaped both wealth rankings and the broader conversation around speculative risk. According to Bloomberg's Billionaire Index, Musk's net worth rose to about $1.
June is a natural moment for mid-year reflection. Short-term traders are squaring quarterly books, but long-term investors should be doing something different: Stepping back to ask which businesses have already produced multi-decade compounding, and whether the moats that drove those returns are still intact today.
The Federal Reserve kept its benchmark federal funds rate unchanged at 3.50%3.75% on Wednesday, a widely anticipated decision that nevertheless rattled financial markets as policymakers signaled a more hawkish outlook for the years ahead. In its latest policy statement, the Fed said the U.S. economy continues to expand at a solid pace despite ongoing uncertainty linked in part to the conflict in the Middle East.
In this week's edition of The Protocol Newsletter, we're looking at how FIFA is using the Avalanche blockchain to test out a new ticketing system.
Michael Saylor used his appearance at the BTC Prague conference to respond to criticism over the sale of 32 Bitcoin that Strategy carried out at the end of May and to offer his own theory on Bitcoin's underperformance in 2025.
Moodys Ratings is expanding its blockchain strategy by bringing its credit ratings infrastructure to the Solana (SOL) network, enabling issuers of tokenized bonds and other fixed-income assets to integrate Moodys credit assessments directly into blockchain-based securities. The initiative, announced in partnership with Solana-focused tokenization firm Alphaledger, extends Moodys Token Integration Engine (TIE) to one of the largest public blockchain networks.
Coinbase Global Inc (NASDAQ:COIN) is accelerating innovation across trading, payments and artificial intelligence, with recent product launches reinforcing its ambition to become a unified exchange for multiple asset classes and potentially broaden its addressable market, Jefferies analysts wrote following the company's System Update event. The analysts highlighted Coinbase's launch of tokenized equities for customers outside the United States, offering 1:1 exposure to underlying stocks, including dividend rights, through fully on-chain assets.
Devon Energy remains a "Buy," with shares offering solid value despite recent oil price volatility and a technical correction from March highs. DVN delivered strong Q1 free cash flow of $816 million, maintained capital discipline, and ended the quarter with a clean balance sheet and $4.8 billion in liquidity. EPS growth is projected to accelerate into FY 2026 and beyond, with 17 recent sellside upgrades and a 12.6% FCF yield supporting the investment case.
Kuros Biosciences AG (CSBTF) Analyst/Investor Day Transcript
Britain's competition watchdog introduced new rules Wednesday requiring Google to be fairer and more transparent in how it ranks search results, as part of moves tackling the technology giant's dominance.
Mexican billionaire Ricardo Salinas Pliego, whose net worth is estimated at around $5 billion, continues to be one of the worlds most outspoken bitcoin advocates. The Grupo Elektra chairman revealed that approximately 70% of his investment portfolio is allocated to bitcoin, reflecting his strong belief that the cryptocurrency is the best long-term store of value and a superior hedge against inflation compared to traditional fiat currencies.
Bitcoin and major cryptocurrencies traded largely unchanged ahead of Kevin Warsh's first FOMC meeting, supported by improving ETF inflows as traders brace for potential volatility around the Fed decision. Cryptocurrency Ticker Price Bitcoin (CRYPTO: BTC) $65,912 Ethereum (CRYPTO: ETH) $1,781 Solana (CRYPTO: SOL) $73.56 XRP (CRYPTO: XRP) $1.21 Dogecoin (CRYPTO: DOGE) $0.08694 Shiba Inu (CRYPTO: SHIB) $0.054986 Notable Statistics: Coinglass data shows 82,131 traders were liquidated in the past 24 hours for $297.87 million.
Allbirds completed its transformation from a footwear company into an artificial intelligence infrastructure provider on Wednesday, changing its name to Smartbird and appointing former Amazon executive Nadia Carlsten as chief executive officer. The announcement sent shares of the company, which continues to trade under the ticker BIRD, sharply higher.
The ETF industry has crossed a historic threshold, comfortably surpassing previous milestones well ahead of schedule. 2026 U.S.-listed ETF flows have reached $1 trillion, less than halfway through the year, according to Bloomberg data.
On June 16, Harbor Capital Advisors launched the Harbor Active Commodity ETF (ACOM). With an expense ratio of 93 basis points, this fund provides actively managed exposure to commodity instruments with a focus on high expected inflation and low cost of carry.
OKX integrated Chainlink Data Streams into the mainnet of X Layer, its ZK L2, with the goal of enabling AI-powered DeFi applications and real-world asset protocols. The integration allows developers to access high-frequency market data in real time, rather than receiving it at scheduled intervals.
The Federal Reserve announced on Wednesday that the first Federal Open Market Committee (FOMC) vote under new chair Kevin Warsh was unanimous in favor of a rate hold, as expected by the market consensus, while the latest economic projections showed nearly half of policymakers believe a rate hike will be warranted in 2026.
Verastem, Inc. is maintained at a Buy rating, driven by upcoming clinical catalysts and positive early-stage data in KRAS G12D mutant solid tumors. VSTM expects key data readouts from the TARGET-D 101 phase 1/2 study in 2026 and is advancing three phase 2 registration-directed studies for PDAC, NSCLC, and CRC for VS-7375. Positive phase 1b/2a RAMP 205 results in 1st-line metastatic PDAC (86% OS at 6 months, 52% cORR) support further development of avutometinib/defactinib combinations.